Investigators recently inspected the company’s facility and found poor sterile production practices, which resulted in the initial product alert. This week that alert was expanded.
The agency has not learned of any adverse events from improperly sterilized NuVision products. The alert is cautionary.
More Articles on Anesthesia:
Study: Anesthesia Not Linked to Dementia, Alzheimer’s in Elderly Patients
Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
FDA Officially Lowers Dose Recommendation for Zolpidem Sleep Drug
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
